NCT03830853

Brief Summary

Following successful CTO PCI, a multitude of physiological and anatomical changes take place. Contemporary techniques such as dissection/re-entry or lumen-lumen wiring may influence the immediate and longer term follow up of these features. It is not known whether changes in this level of physiology and anatomy in the context of CTO vessels correlate with each other, or with quality of life and exercise capacity. This study aims to take physiological measurements of absolute coronary flow, resistance and pressure and intra-coronary imaging immediately after successful CTO PCI. The investigators will relate these to each other and to the method of revascularisation, comparing changes in these groups at three months follow up. QoL measurements, and exercise testing will be carried out to see if there is a relationship between physiological and anatomical changes with exercise capacity and quality of life. Results from this study could shed light on optimisation of CTO PCI procedural and clinical outcomes.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jan 2015

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 23, 2015

Completed
2.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2018

Completed
1.1 years until next milestone

First Submitted

Initial submission to the registry

January 22, 2019

Completed
14 days until next milestone

First Posted

Study publicly available on registry

February 5, 2019

Completed
Last Updated

December 21, 2021

Status Verified

December 1, 2021

Enrollment Period

2.9 years

First QC Date

January 22, 2019

Last Update Submit

December 20, 2021

Conditions

Keywords

CTO - chronic total occlusionOCT - optical coherence tomographycoronary physiologyabsolute flow

Outcome Measures

Primary Outcomes (2)

  • Change in coronary flow

    change in coronary flow at baseline and follow up

    3 months

  • Change in coronary resistance

    change in coronary absolute resistance at baseline and follow up

    3 months

Secondary Outcomes (4)

  • Change in coronary anatomy

    3 months

  • Change in exercise work load

    3 months

  • Change in quality of life

    3 months

  • Change in coronary pressure measurements

    3 months

Study Arms (1)

Successful CTO PCI achieved

Patients will have successful CTO PCI (chronic total occlusion percutaneous coronary intervention) followed by physiological and intracoronary imaging. These measurements will be repeated at a 3 month follow up angiogram procedure.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients who have been selected for elective percutaneous coronary angioplasty (PCI) of their chronic total occlusion (CTO) as part of routine standard of care will be approached for the study.

You may qualify if:

  • years of age
  • Presence of a coronary chronic total occlusion (CTO) scheduled for elective percutaneous coronary angioplasty (PCI)
  • Evidence of viability in the CTO Territory

You may not qualify if:

  • \< 18 year of age
  • Unable to give informed consent
  • Known severe chronic kidney disease (creatinine clearance ≤30 mL/min), unless the patient is on dialysis
  • Unable to receive antiplatelets or periprocedural anticoagulation
  • Contraindications to adenosine
  • Any study lesion characteristic resulting in the expected inability to deliver FD-OCT catheter at the distal vessel post CTO PCI (e.g. moderate or severe vessel calcification or tortuosity)
  • Pregnancy, planning pregnancy during study period, or breastfeeding

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Essex Cardiothoracic Centre

Basildon, Essex, S16 5NL, United Kingdom

Location

Study Officials

  • John Davies, MBBS, PhD

    Basildon and Thurrock University Hospitals

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 22, 2019

First Posted

February 5, 2019

Study Start

January 23, 2015

Primary Completion

January 1, 2018

Study Completion

January 1, 2018

Last Updated

December 21, 2021

Record last verified: 2021-12

Data Sharing

IPD Sharing
Will not share

Locations